Latest Breaking News On - American health drug - Page 1 : vimarsana.com

Background Obesity is a serious disease that is associated with an increased risk of diabetes, hypertension, heart disease, stroke, and cancer, among other diseases. The United States Centers for Disease Control and Prevention (CDC) estimates a 20% obesity rate in the 50 states, with 12 states having rates of over 30%. Currently, the body mass index (BMI) is most commonly used to determine adiposity. However, BMI presents as an inaccurate obesity classification method that underestimates the epidemic and contributes to failed treatment. In this study, we examine the effectiveness of precise biomarkers and duel-energy x-ray absorptiometry (DXA) to help diagnose and treat obesity. Methodology/Principal Findings A cross-sectional study of adults with BMI, DXA, fasting leptin and insulin results were measured from 1998–2009. Of the participants, 63% were females, 37% were males, 75% white, with a mean age = 51.4 (SD = 14.2). Mean BMI was 27.3 (SD = 5.9) and mean percent body fat wa

United statesQamaruddin nizamiVemco mededCerner lifesciencesUniversity of south florida medical schoolNational institute of healthRobert wood johnson foundationBioreference labHealth nutrients incYork state department of healthUnited states centers for diseaseAmerican academy of medicine fellowship in antiAmerican academy of medicine tarsus medical conferencePinnacle health geisinger systemFiona druckenmiller fundAmerican health drug